Clinical Trial Update: A Prospective Epidemiologic Study of ALK-Positive NSCLC in China

View source ↗

Summary

A completed prospective epidemiologic study examining ALK-positive non-small cell lung cancer in China, summarizing prevalence and patient characteristics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Non-small-cell Lung Cancer | Status: COMPLETED